It’s all in your head.
It would be easy to treat this as a series of individual failures—bad doctors, missed diagnoses, unfortunate experiences—but the pattern is too consistent for that to hold. Something else is operating underneath it.
The assumption that never quite gets questioned
For a long time, medical research has been organised around a particular assumption, which is that the male body can stand in for the human body as a whole, and that what applies to one can be generalised to the other without significant consequence5, and that assumption has shaped everything downstream.
Clinical trials historically excluded women, with symptoms being defined based on male presentation5, and treatment protocols were built on that foundation and then extended outward, as though the differences were minor rather than structural, and because of that, the gap doesn’t always appear immediately—it shows up in the margins.
Women in acute pain waiting longer in emergency rooms before receiving treatment1. Heart attack symptoms being misread because they don’t follow the expected pattern2. Conditions such as endometriosis and polycystic ovarian syndrome taking years, sometimes close to a decade, to be diagnosed3, while patients are told to manage, to wait, or to accept that nothing more can be done, and none of this sits as a single failure, instead it accumulates.
What gets recognised, and what doesn’t
Once you begin to look at it this way, the idea that women’s health is simply “underfunded” or “overlooked” starts to feel slightly incomplete, because it suggests a gap that could be closed without changing the structure that produced it.
But the structure itself is doing something more specific—it’s deciding what counts as a reliable body of knowledge, and what doesn’t.
Following on from that, research funding follows that decision4, as does clinical attention, and credibility.
Which means that certain conditions are treated as urgent, measurable, and worth solving, while others are treated as ambiguous, subjective, or peripheral, regardless of their impact, and once that hierarchy is in place, it tends to reproduce itself.
The result isn’t simply that women are occasionally dismissed, it’s that dismissal becomes predictable—not exactly inevitable, but certainly patterned.
Where the responsibility quietly shifts
This is often where the conversation shifts toward individual advocacy, because the proposed solution tends to centre on what women can do differently—ask more questions, seek second opinions, push harder for answers—and while those responses are understandable, they sit slightly uneasily alongside the scale of the problem.
Because they assume that the system itself is functioning, and that the issue is access to it, rather than the way it is structured, and that distinction matters.
Following the pattern outward
The same pattern appears when you follow it outward.
Funding disparities between conditions that primarily affect men and those that primarily affect women do not simply reflect oversight; they reflect prioritisation4.
Reproductive health policies, particularly in countries where access is restricted, don’t emerge in isolation; they sit within a broader framework that regulates whose bodies are subject to control and whose aren’t8,9,10,11.
Healthcare access itself follows similar lines, where systems that are tied to income disproportionately affect those already navigating structural disadvantage, and where universal healthcare models tend to produce different outcomes not because the populations are fundamentally different, but because the underlying assumptions about access have shifted6.
Once the pattern becomes visible
At that point, the question becomes less about individual experiences, and more about the pattern those experiences form when placed side by side, because once the pattern is visible, it becomes difficult to describe what is happening as accidental, and if it’s not accidental, then the question changes again.
It changes not to what went wrong in a particular consultation, or why a diagnosis was delayed, but why the system continues to produce the same outcome across different contexts, different practitioners, and different conditions.
What the system is actually doing
There is a tendency to frame this as something that will correct itself over time, as awareness increases and more women enter the field, and while change is certainly possible, it’s not something that happens independently of the structures that shape it, because those structures aren’t neutral.
They determine what is studied, what is funded, what is believed, and what is dismissed, which leaves something slightly uncomfortable sitting underneath all of this.
If the pattern is consistent, and if the structure producing it has not fundamentally shifted, then the expectation that individual effort alone will resolve it starts to look less convincing.
The question that remains
And that’s usually the point where the conversation becomes more difficult to contain, because it moves beyond the question of whether women are being heard, and into the question of how the system decides what’s worth hearing in the first place.
Footnotes and Research References
- Medical Gaslighting and Gender Bias in Pain Treatment
- Studies have shown that women’s pain is often taken less seriously than men’s. A 2008 study published in Academic Emergency Medicine found that women experiencing acute abdominal pain waited longer to receive pain medication compared to men.
- Source: Chen, E. H., et al. (2008). “Gender Disparity in Analgesic Treatment of Emergency Department Patients with Acute Abdominal Pain.” Academic Emergency Medicine.
- ↩ back to citation
- Heart Attack Symptoms in Women
- Women often experience different heart attack symptoms than men, such as nausea, fatigue, or back pain, rather than the classic chest pain. This leads to misdiagnosis or delayed treatment.
- Source: American Heart Association. (2021). “Heart Attack Symptoms in Women.”
- ↩ back to citation
- Endometriosis Diagnosis Delays
- Research shows that endometriosis takes an average of 7 to 10 years to diagnose, with many women being dismissed or misdiagnosed during that time.
- Source: Nnoaham, K. E., et al. (2011). “Impact of Endometriosis on Quality of Life and Work Productivity: A Multicenter Study Across Ten Countries.” Fertility and Sterility.
- ↩ back to citation
- Funding Disparities in Medical Research
- Conditions like endometriosis receive far less funding compared to conditions that primarily affect men. For example, endometriosis research receives a fraction of the funding allocated to erectile dysfunction research.
- Source: As-Sanie, S., et al. (2019). “Research Priorities for Endometriosis: Recommendations from a Global Consortium of Investigators in Endometriosis.” Reproductive Sciences.
- ↩ back to first citation | ↩ back to second citation
- Gender Bias in Clinical Trials
- Historically, women have been excluded from clinical trials, leading to a lack of understanding about how diseases and treatments affect women differently.
- Source: Liu, K. A., & Mager, N. A. (2016). “Women’s Involvement in Clinical Trials: Historical Perspective and Future Implications.” Pharmacy Practice.
- ↩ back to first citation | ↩ back to second citation
- Universal Healthcare and Women’s Health Outcomes
- Countries with universal healthcare systems tend to have better health outcomes for women, including lower maternal mortality rates and better access to preventive care.
- Source: World Health Organization (WHO). (2020). “Universal Health Coverage and Gender Equality.”
- ↩ back to citation
- Advocacy for Women’s Health Policy
- Organisations like the American Medical Women’s Association (AMWA) and the Society for Women’s Health Research (SWHR) advocate for gender-inclusive research and policy changes to address disparities in women’s healthcare.
- Source: Society for Women’s Health Research. (2023). “Advancing Women’s Health Through Science, Policy, and Education.”
- U.S. Abortion Bans Post-Roe v. Wade
- The overturning of Roe v. Wade in 2022 has led to near-total abortion bans in multiple states, severely restricting access to reproductive healthcare for millions of women. This has created a healthcare crisis, particularly for low-income and marginalised women who cannot afford to travel for care.
- Source: Guttmacher Institute. (2023). “State Bans on Abortion Throughout Pregnancy.”
- ↩ back to citation
- Poland’s Abortion Ban
- In 2020, Poland’s Constitutional Tribunal ruled that abortion is unconstitutional in cases of foetal defects, effectively banning nearly all abortions in the country. This decision has forced women to seek unsafe alternatives or travel abroad for care, putting their health and lives at risk.
- Source: Human Rights Watch. (2020). “Poland’s Constitutional Tribunal Rolls Back Reproductive Rights.”
- ↩ back to citation
- Global Trends in Reproductive Rights
- Around the world, right-leaning governments are adopting restrictive policies on abortion and contraception, mirroring the erosion of reproductive rights in the U.S. Countries like Hungary and parts of Latin America have implemented laws that limit access to essential reproductive healthcare.
- Source: Center for Reproductive Rights. (2023). “The World’s Abortion Laws.”
- ↩ back to citation
- Impact of Abortion Restrictions on Women’s Health
- ACOG has consistently emphasised that restrictive abortion policies harm women’s health by limiting access to safe, timely care. They highlight that such restrictions disproportionately affect marginalised communities, increase maternal mortality rates, and force women to seek unsafe alternatives.
- Source: American College of Obstetricians and Gynecologists (ACOG). (2022). “Abortion Policy and Women’s Health.”
- ↩ back to citation
About the author
Estelle is the Editor and Founder of Smart Healthy Women Magazine. Founded online in 2013, SHW began as a wellness publication and evolved, over more than a decade, into a feminist political magazine, covering the health, economic, and political conditions shaping women's lives in a world that increasingly demands honest writing about both. SHW has published 677 articles and 56 themed digital issues featuring the work of more than 300 women writers.




